https://www.justajournals.com/
Latest
New target for drug development could fill a major gap in depression treatment - News-Medical.net
Health Mon Nov 15 2021

New target for drug development could fill a major gap in depression treatment - News-Medical.net

News-Medical.Net
THE IDEA Vanderbilt researchers found that ketamine's rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap i… [+2414 chars] Vanderbilt researchers found that ketamine's rapid antidepressant action is due to specific synaptic effects. Read More
Most Popular
Most Recent

SUBSCRIBE TO ALL THE NEWS

Never miss the latest updates.

Related